BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16894342)

  • 1. Antiangiogenic therapies in endometriosis.
    Ferrero S; Ragni N; Remorgida V
    Br J Pharmacol; 2006 Sep; 149(2):133-5. PubMed ID: 16894342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises.
    Van Langendonckt A; Donnez J; Defrère S; Dunselman GA; Groothuis PG
    Mol Hum Reprod; 2008 May; 14(5):259-68. PubMed ID: 18430758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate causes regression of endometriotic implants: a rat model.
    Onalan G; Zeyneloglu HB; Bayraktar N
    Fertil Steril; 2009 Dec; 92(6):2100-2. PubMed ID: 19580963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model.
    Xu H; Lui WT; Chu CY; Ng PS; Wang CC; Rogers MS
    Hum Reprod; 2009 Mar; 24(3):608-18. PubMed ID: 19088106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis.
    Rudzitis-Auth J; Menger MD; Laschke MW
    Hum Reprod; 2013 May; 28(5):1339-47. PubMed ID: 23427233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effects of Sanleng pellet on angiogenesis of endometriosis in rats].
    Chen Y; Xu XY; Ye L; Zhu HF; Chen H; Chen G
    Zhongguo Zhong Yao Za Zhi; 2008 Feb; 33(3):303-7. PubMed ID: 18536472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models for anti-angiogenic therapy in endometriosis.
    Edwards AK; Nakamura DS; Virani S; Wessels JM; Tayade C
    J Reprod Immunol; 2013 Mar; 97(1):85-94. PubMed ID: 23432875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant human endostatin on endometriosis in mice.
    Jiang HQ; Li YL; Zou J
    Chin Med J (Engl); 2007 Jul; 120(14):1241-6. PubMed ID: 17697575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis and antiangiogenic therapy in endometriosis.
    Becker CM; D'Amato RJ
    Microvasc Res; 2007; 74(2-3):121-30. PubMed ID: 17574280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of endometriosis.
    Huang HY
    Chang Gung Med J; 2008; 31(5):431-40. PubMed ID: 19097589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenesis therapy for endometriosis.
    Nap AW; Griffioen AW; Dunselman GA; Bouma-Ter Steege JC; Thijssen VL; Evers JL; Groothuis PG
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1089-95. PubMed ID: 15001592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin induces regression of endometriotic lesions by inhibiting neovascularization and cell proliferation.
    Laschke MW; Elitzsch A; Scheuer C; Holstein JH; Vollmar B; Menger MD
    Br J Pharmacol; 2006 Sep; 149(2):137-44. PubMed ID: 16894343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions.
    Bourlev V; Volkov N; Pavlovitch S; Lets N; Larsson A; Olovsson M
    Reproduction; 2006 Sep; 132(3):501-9. PubMed ID: 16940291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis.
    Tesone M; Bilotas M; Barañao RI; Meresman G
    Gynecol Obstet Invest; 2008; 66 Suppl 1():10-8. PubMed ID: 18936547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometriosis: current and future medical therapies.
    Vercellini P; Somigliana E; Viganò P; Abbiati A; Daguati R; Crosignani PG
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):275-306. PubMed ID: 18036995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-methoxyestradiol in the pathophysiology of endometriosis: focus on angiogenesis and therapeutic potential.
    Machado-Linde F; Pelegrin P; Sanchez-Ferrer ML; Leon J; Cascales P; Parrilla JJ
    Reprod Sci; 2012 Oct; 19(10):1018-29. PubMed ID: 22875846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane.
    Nap AW; Dunselman GA; Griffioen AW; Mayo KH; Evers JL; Groothuis PG
    Fertil Steril; 2005 Mar; 83(3):793-5. PubMed ID: 15749522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative medical treatment for endometriosis.
    Taylor H; Guarnaccia M; Olive D
    Semin Reprod Endocrinol; 1997; 15(3):285-90. PubMed ID: 9383837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis.
    Laschke MW; Menger MD
    Hum Reprod Update; 2007; 13(4):331-42. PubMed ID: 17347159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.